- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Indian Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Results
2
0 new
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
2 companies
NATCO Pharma
Market Cap: ₹158.2b
A pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.
NATCOPHARM
₹883.40
7D
0.4%
1Y
-11.7%
Jenburkt Pharmaceuticals
Market Cap: ₹5.0b
Researches and develops, manufactures, and markets pharmaceutical and healthcare products in India.
524731
₹1,133.90
7D
-4.0%
1Y
38.0%